Abstract
Immunosuppression and comorbidities might place solid organ transplant (SOT) recipients at higher risk from COVID-19, as suggested by recent case series. We compared 45 SOT vs. 2427 non-SOT patients who were admitted with COVID-19 to our health-care system (March 1, 2020 - August 21, 2020), evaluating hospital length-of-stay and inpatient mortality using competing-risks regression. We compared trajectories of WHO COVID-19 severity scale using mixed-effects ordinal logistic regression, adjusting for severity score at admission. SOT and non-SOT patients had comparable age, sex, and race, but SOT recipients were more likely to have diabetes (60% vs. 34%, p
Author supplied keywords
Cite
CITATION STYLE
Avery, R. K., Chiang, T. P. Y., Marr, K. A., Brennan, D. C., Sait, A. S., Garibaldi, B. T., … Massie, A. B. (2021). Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. American Journal of Transplantation, 21(7), 2498–2508. https://doi.org/10.1111/ajt.16431
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.